Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Change in Cash (2016 - 2025)

Historic Change in Cash for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to -$1.5 million.

  • Assembly Biosciences' Change in Cash fell 11592.38% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.9 million, marking a year-over-year decrease of 42951.0%. This contributed to the annual value of $18.5 million for FY2024, which is 15679.77% up from last year.
  • Per Assembly Biosciences' latest filing, its Change in Cash stood at -$1.5 million for Q3 2025, which was down 11592.38% from $593000.0 recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Change in Cash ranged from a high of $18.8 million in Q1 2021 and a low of -$25.1 million during Q4 2021
  • Its 5-year average for Change in Cash is -$1.9 million, with a median of -$1.1 million in 2024.
  • The largest annual percentage gain for Assembly Biosciences' Change in Cash in the last 5 years was 52689.51% (2021), contrasted with its biggest fall of 231827.01% (2021).
  • Quarter analysis of 5 years shows Assembly Biosciences' Change in Cash stood at -$25.1 million in 2021, then soared by 91.03% to -$2.3 million in 2022, then tumbled by 202.22% to -$6.8 million in 2023, then surged by 245.15% to $9.9 million in 2024, then tumbled by 114.88% to -$1.5 million in 2025.
  • Its last three reported values are -$1.5 million in Q3 2025, $593000.0 for Q2 2025, and -$14.9 million during Q1 2025.